US Tardive Dyskinesia Treatment Market - 2031-2023
Description
US Tardive Dyskinesia Treatment Market Overview:
The US Tardive Dyskinesia Treatment Market was valued at US$ 6417.43 million in 2031 and is anticipated to reach US$ 3061.64 million by 2023, at a CAGR of 0.098 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the US Tardive Dyskinesia Treatment Market.
This report delivers a comprehensive overview of the US Tardive Dyskinesia Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding US Tardive Dyskinesia Treatment Market. The US Tardive Dyskinesia Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2031–2023.
US Tardive Dyskinesia Treatment Market Scope:
Major Highlights
This report delivers a comprehensive overview of the US Tardive Dyskinesia Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding US Tardive Dyskinesia Treatment Market. The US Tardive Dyskinesia Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2031–2023.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
The US Tardive Dyskinesia Treatment Market was valued at US$ 6417.43 million in 2031 and is anticipated to reach US$ 3061.64 million by 2023, at a CAGR of 0.098 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the US Tardive Dyskinesia Treatment Market.
This report delivers a comprehensive overview of the US Tardive Dyskinesia Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding US Tardive Dyskinesia Treatment Market. The US Tardive Dyskinesia Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2031–2023.
US Tardive Dyskinesia Treatment Market Scope:
Major Highlights
This report delivers a comprehensive overview of the US Tardive Dyskinesia Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding US Tardive Dyskinesia Treatment Market. The US Tardive Dyskinesia Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2031–2023.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
South America (Colombia, Brazil, Argentina, Rest of South America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Partner Identification
Increase Your Customer Base by 3X using our Partner Identification tool
Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
Prioritize partners by strategic fit rather than general capability.
Why Choose DataM?
• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
Target Audience 2026
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
Table of Contents
223 Pages
- 1. U.S. Tardive Dyskinesia Treatment Market – Methodology and Scope
- 1.1. Research Methodology
- 1.2. Scope of the Report
- 2. U.S. Tardive Dyskinesia Treatment Market – Definition and Overview
- 3. U.S. Tardive Dyskinesia Treatment Market – Executive Summary
- 3.1. Market Snippet by Drug
- 3.2. Market Snippet by Distribution Channel
- 3.3. Market Snippet by Region
- 4. U.S. Tardive Dyskinesia Treatment Market – Market Dynamics
- 4.1. Market Drivers
- 4.1.1. Increasing clinical approvals
- 4.1.2. Prolonged use of antipsychotic drugs by patients
- 4.1.3. An increase in the aging population
- 4.2. Market Restraints
- 4.2.1. Side effects associated with the drugs
- 4.2.2. Lack of awareness about the disorder
- 4.3. Market Opportunity
- 4.4. Emerging Countries
- 4.5. The development of novel therapies
- 4.6. Impact Analysis
- 5. U.S. Tardive Dyskinesia Treatment Market – Industry Factors
- 5.1. Porter’s Five Force Analysis
- 5.2. Regulatory Analysis
- 5.3. Supply Chain Analysis
- 5.4. Pricing Analysis
- 5.5. Patent Analysis
- 5.6. SWOT Analysis
- 5.7. Unmet Needs
- 5.8. Epidemiology Analysis
- 6. U.S. Tardive Dyskinesia Treatment Market – COVID-19
- 6.1. Analysis of COVID-19 on the Market*
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario After COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. U.S. Tardive Dyskinesia Treatment Market – By Drug
- 7.1. Introduction
- 7.1.1. Market Size and Y-o-Y Growth Analysis (%), By Drug
- 7.1.2. Market Attractiveness Index, By Drug
- 7.2. Valbenazine*
- 7.2.1. Introduction
- 7.2.2. Market Size, 2022-2031 and Y-o-Y Growth (%), 2023-2031
- 7.3. Tetrabenazine
- 7.4. Deutetrabenazine
- 7.5. Amantadine
- 7.6. Clonazepam
- 7.7. Others
- 8. U.S. Tardive Dyskinesia Treatment Market – By Distribution Channel
- 8.1. Introduction
- 8.1.1. Market Size and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
- 9. Hospital and Speciality Pharmacies*
- 9.1. Introduction
- 9.2. Market Size, 2022-2031 and Y-o-Y Growth (%), 2023-2031
- 10. Retail Pharmacies
- 11. Others
- 12. U.S. Tardive Dyskinesia Treatment Market – Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. U.S. Tardive Dyskinesia Treatment Market – Company Profiles
- 13.1. Teva Pharmaceutical Industries Ltd*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Key Highlights
- 13.1.4. Financial Overview
- 13.2. Neurocrine Biosciences, Inc.
- 13.3. Lupin Limited
- 13.4. Accord Healthcare, Inc.
- 13.5. Mitsubishi Corporation
- 13.6. Dr. Reddy’s Laboratories Limited
- 13.7. BIONPHARMA INC.
- 13.8. Slate Run Pharmaceuticals
- 13.9. Aurobindo Pharma Limited
- 13.10. Apotex Inc.
- 14. U.S. Tardive Dyskinesia Treatment Market – DataM
- 14.1. Appendix
- 14.2. About Us and Services
- 14.3. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
